Cardiovascular and Renal Drugs Advisory Committee Roster
Applying for Membership on FDA Advisory Committees
As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)
Current Number of Vacancies = 0
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
Chairperson
Julia B. Lewis, MD
Expertise: Internal Medicine, Nephrology
Term: 8/24/2017 – 6/30/2021
Professor of Medicine
Division of Nephrology
Vanderbilt Medical Center
1161 21st Avenue South, S-3223 MCN
Nashville, Tennessee 37232
Designated Federal Officer
Jennifer A. Shepherd, RPh
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: CRDAC@fda.hhs.gov
John H. Alexander, MD, MHSc
Expertise: Cardiology
Term: 7/1/2016 – 6/30/2020
Professor of Medicine
Department of Medicine, Division of Cardiology
Duke University School of Medicine
2400 Pratt Street,
Durham, North Carolina 27710
*Jacqueline D. Alikhaani, BA
Expertise: Consumer Representative
Term: 6/11/2019 – 6/30/2023
Volunteer and Advocate
American Heart Association
Los Angeles, CA 90017
Peter E. Carson, MD
Expertise: Cardiology
Term: 8/28/2019 – 6/30/2023
Clinical Professor of Medicine Georgetown University
Chief Heart Failure Service
Veterans Affairs Medical Center
50 Irving Street, NW
Washington, DC 20422
Barry R. Davis, MD, PhD
Expertise: Biostatistics
Term: 2/5/2015 – 6/30/2020
Guy S. Parcel Chair in Public Health
Professor, Department of Biostatistics and Data Science
Director, Coordinating Center for Clinical Trials
The University of Texas School of Public Health
1200 Pressler Street, W-916
Houston, Texas 77030
C. Michael Gibson, MD, MS
Expertise: Cardiology and Clinical Trials
Term: 8/24/2017 – 6/30/2021
Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Division of Cardiology, Interventional Cardiology
330 Brookline Avenue, OV-540
Boston, Massachusetts 02215
John M. Mandrola, MD, FACC
Expertise: Cardiology, Electrophysiology
Term: 11/14/2017 – 6/30/2020
Electrophysiologist
Baptist Medical Associates
3900 Kesge Way
Louisville, Kentucky 40207
David J. Moliterno, MD
Expertise: Cardiology, Cardiovascular Clinical Research
Term: 2/27/2019 – 6/30/2022
Professor and Chairman
Department of Internal Medicine
University of Kentucky Medical Center
900 South Limestone Street
329 Charles T. Wethington Building
Lexington, Kentucky 40536
Patrick H. Nachman, MD
Expertise: Nephrology
Term: 4/18/2016 – 6/30/2020
Director, Renal Diseases and Hypertension Division
Department of Medicine
University of Minnesota
717 Delaware Street Southeast, Suite 353
Minneapolis, Minnesota 55414
Milton Packer, MD
Expertise: Cardiology, Clinical Trial Design
Term: 7/1/2016 – 6/30/2020
Distinguished Scholar in Cardiovascular Medicine
Baylor Heart and Vascular Institute
Baylor University Medical Center
621 North Hall Street
Dallas, Texas 75226
Paul M. Ridker, MD MPH, FACC, FAHA
Expertise: Cardiology, Coronary Artery Disease
Term: 11/14/2017 – 6/30/2021
Eugene Braunwald Professor of Medicine, Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Division of Preventative Medicine
Brigham and Women’s Hospital
900 Commonwealth Avenue East
Boston, Massachusetts 02215
**Scott M. Wasserman, MD, FACC
Expertise: Cardiovascular Medicine
Term: 2/29/2016 – 10/31/2019
Vice President, Global Development
Cardiovascular and Metabolic Therapeutic Area Head and Head of Development Design Center
Amgen
One Amgen Center Drive
Thousand Oaks, California 91320
*Consumer Representative
** Industry Representative (non voting)